CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −9,377 | 93,765 | ||
| 2026-09-16 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +53,091 | $12.14 | $645K | 283,804 |
| 2026-09-16 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +13,398 | $8.46 | $113K | 297,202 |
| 2026-09-16 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +15,629 | $3.99 | $62K | 312,831 |
| 2026-09-16 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +23,442 | $8.12 | $190K | 336,273 |
| 2026-09-16 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −107,537 | $28.02 | $3.0M | 228,736 |
| 2026-09-16 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −7,869 | $28.57 | $225K | 220,867 |
| 2026-09-16 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −53,091 | 79,155 | ||
| 2026-09-16 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −13,398 | 24,113 | ||
| 2026-09-16 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −15,629 | 65,636 | ||
| 2026-09-16 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −23,442 | 103,142 | ||
| 2026-09-15 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale 10b5-1 | −1,195 | $27.00 | $32K | 395,794 |
| 2026-08-31 | OWEN KATEY EINTERZ Director | Gift | −12,539 | 66,100 | ||
| 2026-08-26 | OWEN KATEY EINTERZ Director | Sale | −9,615 | $26.00 | $250K | 78,639 |
| 2026-08-18 | HERSHBERG ROBERT Director | Option exercise | +15,000 | $6.32 | $95K | 77,347 |
| 2026-08-18 | HERSHBERG ROBERT Director | Sale | −15,000 | $24.39 | $366K | 62,347 |
| 2026-08-18 | HERSHBERG ROBERT Director | Sale | −15,664 | $24.41 | $382K | 46,683 |
| 2026-08-18 | HERSHBERG ROBERT Director | Option exercise · Stock Option (right to buy) | −15,000 | 0 | ||
| 2026-08-18 | ROBINS CHAD M CEO and Chairman | Option exercise | +278,676 | $6.55 | $1.8M | 2,459,194 |
| 2026-08-18 | ROBINS CHAD M CEO and Chairman | Sale | −278,472 | $24.48 | $6.8M | 2,180,722 |
Page 7 of 119 · 2,375 trades